Overview

Methylene Blue for the Treatment of Septic Shock

Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of methylene blue among adult patients with septic shock.
Phase:
PHASE3
Details
Lead Sponsor:
Northern Jiangsu People's Hospital
Treatments:
Methylene Blue